223 related articles for article (PubMed ID: 27796148)
1. The potential use of urine cell free DNA as a marker for cancer.
Salvi S; Martignano F; Molinari C; Gurioli G; Calistri D; De Giorgi U; Conteduca V; Casadio V
Expert Rev Mol Diagn; 2016 Dec; 16(12):1283-1290. PubMed ID: 27796148
[TBL] [Abstract][Full Text] [Related]
2. DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies.
Larsen LK; Lind GE; Guldberg P; Dahl C
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151158
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
4. The study of DNA methylation in urological cancer: present and future.
Andrés G; Ashour N; Sánchez-Chapado M; Ropero S; Angulo JC
Actas Urol Esp; 2013 Jun; 37(6):368-75. PubMed ID: 23643196
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in germ cell tumors: biology and clinical management.
Chovanec M; Kalavska K; Mego M; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083
[No Abstract] [Full Text] [Related]
6. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
[No Abstract] [Full Text] [Related]
7. Urinary Cell-Free DNA: Potential and Applications.
Salvi S; Casadio V
Methods Mol Biol; 2019; 1909():201-209. PubMed ID: 30580433
[TBL] [Abstract][Full Text] [Related]
8. Urinary Biomarkers in Tumors: An Overview.
Cimmino I; Bravaccini S; Cerchione C
Methods Mol Biol; 2021; 2292():3-15. PubMed ID: 33651347
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of molecular genetic cancer profiling.
Joseph L
Expert Rev Mol Diagn; 2016 Aug; 16(8):827-38. PubMed ID: 27253039
[TBL] [Abstract][Full Text] [Related]
11. DNA alterations in body fluids as molecular tumor markers for urological malignancies.
Goessl C; Müller M; Straub B; Miller K
Eur Urol; 2002 Jun; 41(6):668-76. PubMed ID: 12074786
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
13. The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancer.
He WS; Bishop KS
Expert Rev Mol Diagn; 2016 Aug; 16(8):839-52. PubMed ID: 27254598
[TBL] [Abstract][Full Text] [Related]
14. New method to preserve the original proportion and integrity of urinary cell-free DNA.
Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y
J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467
[TBL] [Abstract][Full Text] [Related]
15. [Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies].
Ellinger J; von Rücker A; Bastian PJ; Müller SC
Urologe A; 2010 Sep; 49(9):1131-2, 1134. PubMed ID: 20628864
[TBL] [Abstract][Full Text] [Related]
16. Role of Circulating Cell-Free DNA in Cancers.
Aarthy R; Mani S; Velusami S; Sundarsingh S; Rajkumar T
Mol Diagn Ther; 2015 Dec; 19(6):339-50. PubMed ID: 26400814
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer.
Wang J; Han X; Sun Y
Sci China Life Sci; 2017 Apr; 60(4):356-362. PubMed ID: 28063009
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
Müller M; Goessl C; Krause H; Miller K
Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
[TBL] [Abstract][Full Text] [Related]
19. Circulating biomarkers to guide systemic therapy for urothelial carcinoma.
Abbosh PH; Rosenberg JE; Plimack ER
Urol Oncol; 2016 Nov; 34(11):502-509. PubMed ID: 27751785
[TBL] [Abstract][Full Text] [Related]
20. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
